Yasuo Yoshioka
Etsushi Kuroda
Toshiro Hirai
Yasuo Tsutsumi4,7- 1Vaccine Creation Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
- 2BIKEN Center for Innovative Vaccine Research and Development, The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan
- 3Laboratory of Nano-Design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan
- 4The Center for Advanced Medical Engineering and Informatics, Osaka University, Suita, Osaka, Japan
- 5Laboratory of Vaccine Science, Immunology Frontier Research Center, World Premier International Research Center, Osaka University, Suita, Osaka, Japan
- 6Department of Dermatology and Immunology, University of Pittsburgh, Pittsburgh, PA, USA
- 7Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan
- 8Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan
Over the past decade, a vast array of nanomaterials has been created through the development of nanotechnology. With the increasing application of these nanomaterials in various fields, such as foods, cosmetics, and medicines, there has been concern about their safety, that is, nanotoxicity. Therefore, there is an urgent need to collect information about the biological effects of nanomaterials so that we can exploit their potential benefits and design safer nanomaterials, while avoiding nanotoxicity as a result of inhalation or skin exposure. In particular, the immunomodulating effect of nanomaterials is one of most interesting aspects of nanotoxicity. However, the immunomodulating effects of nanomaterials through skin exposure have not been adequately discussed compared with the effects of inhalation exposure, because skin penetration by nanomaterials is thought to be extremely low under normal conditions. On the other hand, the immunomodulatory effects of nanomaterials via skin may cause severe problems for people with impaired skin barrier function, because some nanomaterials could penetrate the deep layers of their allergic or damaged skin. In addition, some studies, including ours, have shown that nanomaterials could exhibit significant immunomodulating effects even if they do not penetrate the skin. In this review, we summarize our current knowledge of the allergic responses induced by nanomaterials upon skin exposure. First, we discuss nanomaterial penetration of the intact or impaired skin barrier. Next, we describe the immunomodulating effects of nanomaterials, focusing on the sensitization potential of nanomaterials and the effects of co-exposure of nanomaterials with substances such as chemical sensitizers or allergens, on the onset of allergy, following skin exposure. Finally, we discuss the potential mechanisms underlying the immunomodulating effects of nanomaterials by describing the involvement of the protein corona in the interaction of nanomaterials with biological components and by presenting recent data about the adjuvant effects of well-characterized particle adjuvant, aluminum salt, as an example of immunomodulatory particulate.
Introduction
Recently, advances in nanotechnology have made possible the design and production of many engineered nanomaterials—nanoparticles, nanofibers, and nanosheets—which are defined as materials with structures having at least one dimension less than 100 nm (1, 2). These products have become indispensable in various fields, such as electronics, foods, cosmetics, and medicines, because nanomaterials have unique physicochemical properties and exert innovative functions compared with conventional larger particles; these properties and functions include enhanced electrical conductivity, tensile strength, and chemical reactivity, and stem from an increase in the surface area per unit weight compared with a larger amount (>100 nm) of the same material (3, 4). However, with the increasing use of nanomaterials, concerns about their safety, termed nanotoxicity, have been raised, specifically that the innovative functions of nanomaterials, such as high chemical reactivity and high tissue penetration, due to their small size might make them hazardous in some situations (5, 6). For example, our group has shown that intravenous injection of a large amount of silica (SiO2) nanoparticles induced pregnancy complications in mice, although it should be noted that the level of exposure used in the study is not representative of real-world human exposure (7). The health risks of engineered nanomaterials to humans have also been considered (8–10). Among the nanotoxic effects, those on host immunity are of particular interest, because the immune cells recognize foreign substances as part of the body’s defenses, when those substances enter the body. Therefore, there have been many reports about the immunomodulating effects, both immune-activating and -suppressing effects, of nanomaterials in vitro and in vivo (11–13). To fully utilize the potential benefits of nanomaterials and design safer nanomaterials, it is essential for us to collect more information about nanotoxicity, because intentional and unintentional exposure to nanomaterials is unavoidable in our everyday life.
Our skin is exposed to nanomaterials in many situations, because nanomaterials are contained in cosmetics and other skincare products. For example, some nanoparticles, especially Zinc oxide (ZnO) and titanium dioxide (TiO2) nanoparticles, have been used in sunscreens since the 1980s, because they have better ultraviolet (UV) protective properties than larger particles (14). SiO2 nanoparticles are used in a wide variety of cosmetics as an anti-setting agent (15). We are also exposed to silver (Ag) nanoparticles through our everyday lives because Ag nanoparticles have been widely applied to consumer products such as clothing, antibacterial sprays, detergent, socks, and shoes for antimicrobial purposes (16). Therefore, an understanding of the absorption rate of nanomaterials after exposure via the skin has attracted increasing attention over the past few years, because it is important to consider the immunomodulatory effects of nanomaterials on the skin. In addition, because nanomaterials can interact with other substances easily (17), we must not forget that exposure to nanomaterials via skin often occurs simultaneously with exposure to other chemical compounds and allergens, such as foods and pollen and that this interaction might modulate the antigenicity of these compounds. Many recent reports have shown that skin is an important site for the onset of allergy (18, 19). For example, several reports have shown that transdermal exposure to food allergens can induce Th2-type immune responses and be sufficient to sensitize mice (20–22). Furthermore, individuals who used a facial soap containing hydrolyzed wheat protein were presumed to be sensitized to this protein (23, 24). Given these findings, there is an urgent need to understand the immunomodulatory effects of nanomaterials upon skin exposure, particularly effects that may lead to the onset or aggravation of allergy. However, while there have been many studies examining the nanotoxicity of nanomaterials to the respiratory system, there is a lack of knowledge about nanotoxicity following skin exposure to nanomaterials, especially the immunomodulating effects.
In this review, we summarize our current understanding of the skin penetration of nanomaterials and the immunomodulating effects of nanomaterials, focusing on the skin penetration of nanomaterials, the sensitization potential of nanomaterials, and the effects of co-exposure of nanomaterials with allergens on the onset of allergy upon skin exposure. In addition, we discuss potential mechanisms underlying the immunomodulating effects of nanomaterials by describing the involvement of the protein corona in the interaction of nanomaterials with complement proteins and by presenting recent study about the adjuvant effects of aluminum salts, which are well characterized in basic immunology.
Skin Structure and Penetration of Skin by Nanomaterials
The skin is composed of several barriers that prevent foreign substances from penetrating the body (25, 26). Healthy skin is divided into the epidermis and the dermis. In addition, there are two physical barriers in the epidermis: the stratum corneum, the outmost layer of the epidermis, and tight junctions, which are intercellular junctions that seal adjacent keratinocytes in the stratum granulosum below the stratum corneum (25, 26). It is generally believed that molecules, other than small lipophilic molecules (<500 Da), are unable to penetrate healthy skin due to these barrier functions (27). The skin also contains hair follicles and sebaceous glands (28). Hair follicles extend into the dermis and might provide a means for penetration and absorption of compounds into the skin. Therefore, hair follicles may play an important role as a potential reservoir and penetration route for topically applied substances. It is also suggested that hair follicles have important functions in immune responses such as those regulating the trafficking of antigen presenting cells (29). In addition, many immune cells such as antigen presenting cells [e.g., Langerhans cells (LCs) in the epidermis and dermal dendritic cells in the dermis] and leukocytes are present in the skin to protect the body from external substances (30). Recently, tape stripping of murine skin showed that activated LCs could elongate their dendrites above the tight junctions of keratinocytes and take up antigens on the surface of the skin (31, 32).
Whether nanomaterials can penetrate the skin barrier in vivo remains controversial, although there have been several reports assessing the skin penetration of nanomaterials after topical application using both in vitro and in vivo models (Figure 1). Because TiO2 and ZnO nanoparticles are essential components in sunscreens, many studies have examined the penetration rate of these nanoparticles, although it should be noted that these nanoparticles are typically present in sunscreens as 30- to 150-nm aggregates. Cross et al. and Larese et al. have shown that ZnO nanoparticles with diameters of 15–40 nm, and Ag nanoparticles with a diameter of 25 nm, can penetrate the upper layers of the stratum corneum but cannot reach the deeper layers of the viable epidermis and dermis by using an in vitro model of human skin (33, 34). Lin et al. also showed that ZnO nanoparticles with a diameter of 10–50 nm could not penetrate healthy skin or tape-stripped skin of human volunteers (35). These reports suggest that the stratum corneum and tight junctions of skin provide an effective barrier to prevent nanomaterial penetration of healthy skin. In contrast, Gulson et al. have shown that small amounts of ZnO nanoparticles with a diameter of 19 nm can penetrate the skin after repeated application to healthy humans (36, 37). These results suggest that nanomaterials may penetrate the skin after repeated application to even healthy skin (Figure 1). However, these different results might be due to differences in the analytical methods used, in the detection sensitivity of the analytical methods, in the sample volume or skin model used, or in the type of nanomaterials and their aggregation state. For example, although Gulson et al. used ZnO particles containing the stable isotope 68Zn and were able to detect the concentration of 68Zn in the body at high sensitivity (36, 37), other groups used conventional nanomaterials and transmission electron microscopy and inductively coupled plasma mass spectrometry techniques in their studies (33–35). In addition, although transmission electron microscopy and mass spectrometry techniques are useful for evaluating the penetration of skin by nanomaterials, transmission electron microscopy is a qualitative method that cannot be used to determine the amount of nanomaterials in the skin, and inductively coupled plasma mass spectrometry is a quantitative method that cannot distinguish between nanomaterials and their dissociated ions. Therefore, the development of more sensitive qualitative and quantitative analysis methods is an important step in elucidating the penetration of nanomaterials through the skin.
Figure 1. Penetration of skin by nanomaterials. After topical application to healthy skin, nanomaterials may penetrate to the stratum corneum or epidermis. However, after application to allergic or damaged skin, nanomaterials may penetrate to the epidermis and dermis.
The skin barrier is not always intact because skin is under constant assault every day by mechanical irritation, mechanical damage (cuts or scrapes), UV exposure, microbial pathogens, and the use of harsh soaps or cosmetic products that may contain chemical irritants (25). In addition, people with healthy skin and those with impaired skin barrier function apply sunscreens containing nanomaterials. In this regard, some studies have examined whether nanomaterials can penetrate deeply into allergic or damaged skin because nanomaterials may be able to penetrate skin with impaired barrier function. Ilves et al. showed that ZnO nanoparticles with a diameter of 20 nm could be observed in the epidermis and to a lesser extent also in the dermis of allergic skin of mice after topical application, but ZnO particles with a diameter of 240 nm were not detected (38). Similar to their observations, other studies using human skin explants with partially disrupted stratum corneum have shown that 40-nm polystyrene nanoparticles, but not 750- or 1500, and 40-nm SiO2 nanoparticles can translocate to the viable epidermis (39, 40). In addition, Mortensen et al. showed that quantum dot nanoparticles with a diameter of 45 nm could penetrate deep into the epidermis and dermis in sub-erythemal dose UV radiation-exposed mice (41). These reports suggest that nanomaterials generally can penetrate the deep layers of the skin, such as the epidermis and the dermis of allergic or damaged skin (Figure 1). Although the precise number of penetrated nanoparticles needs to be quantified, these findings emphasize the importance of investigating the immunomodulatory effects of nanomaterials after topical application.
Recently, hair follicles have been considered an excellent target route for drug delivery via skin (42). Many researchers have tried to deliver drug compounds via hair follicles by using particles such as liposomes (42, 43). Hair follicles have the potential to be efficient, long-term reservoirs suited for accumulation of nanomaterials. Therefore, the hair follicular pathway may be one of the penetration pathways of nanomaterials, although it remains largely unknown whether nanomaterials can indeed penetrate the skin via hair follicles (44, 45).
Sensitization Potential of Nanomaterials on Skin
Allergic contact dermatitis induced by chemicals is the most frequent manifestation of skin sensitization in humans (46). It is estimated that about 4,000 chemicals have the potential to be skin sensitizers (47). Because sensitization to chemicals is sometimes induced at relatively low levels of exposure to that substance via skin exposure, the sensitization potential of nanomaterials might be an important potential nanotoxicity.
Park et al. showed that neither amine-modified polystyrene nanoparticles with a dimeter of 50 nm nor TiO2 nanoparticles (primary size <25 nm) induced skin sensitization after topical skin treatment, as assessed using a local lymph node assay (LLNA), which is a useful method for evaluating the sensitization potential of chemicals (48). Lee et al. evaluated the sensitization potential of two types of SiO2 nanoparticles, mesoporous SiO2, and colloidal SiO2, with diameters of about 100 nm (49). Changes in ear skin thickness after painting the skin with each nanoparticle for three consecutive days were small. In addition, these authors also found that neither nanoparticle induced skin sensitization, as assessed using a LLNA. These results suggest that the sensitization potential of many nanomaterials after topical application to healthy skin might be low. Skin painting is a typical method used to analyze the sensitization potential of chemical compounds, but nanomaterials do not easily penetrate healthy skin. Therefore, subcutaneous or intradermal administration might be useful as alternative routes for examining the sensitization potential of nanomaterials, assuming that the particles are able to penetrate allergic or damaged skin.
Epidemiological studies have suggested that sensitizer metals contained in airborne particulates may also contribute to the onset of metal allergy (50–52). Since metal nanoparticles can release metal ions, we must pay attention to the sensitization potential of not only nanoparticles but also metal ions released from metal nanoparticles. Metal allergy, which is a major cause of allergic contact dermatitis, is prevalent in the general population, and up to 17% of women are reported to suffer from it (53, 54). Nickel is the most frequent cause of metal allergy, but gold, palladium, cobalt, mercury, beryllium, chromium, and silver also have sensitization potential (54). It is suggested that metal ions from jewelry and clothes (buttons, zippers, and belt buckles) cause metal allergy via the activation of innate and adaptive immunity. Although it is believed that metal allergy is caused by metal-ion-induced T cells, which are generally reactive to metal ions in the major histocompatibility complex, many attempts to sensitize mice by means of simple metal-ion treatment have failed (55, 56). Moreover, while some reports have shown that metal allergy in mice can be induced by concomitant application of inflammatory stimuli, such as lipopolysaccharide (LPS) (57, 58), the skin reactions in these models could be induced by irritant inflammation rather than allergic responses (59). Nevertheless, these studies raised the possibility that other unknown factors may contribute to the onset of metal allergy.
Recently, it was revealed that metal nanoparticles are generated in the environment and in our bodies naturally during our daily lives (60). For example, Glover et al. showed that metal nanoparticles were generated spontaneously from manmade objects such as earrings or metal wire, suggesting that macroscale metal objects might be a potential source of naturally occurring nanoparticles in the environment (61). In addition, naturally occurring metal nanoparticles are thought to be formed from ions via chemical and/or photochemical reduction of released metal ions from metal objects (61, 62). Therefore, we could be extemporaneously exposed to metal ions from metal objects when we wear metal accessories and then these ions could generate naturally occurring metal nanoparticles when we are sensitized to metal. In this regard, our group examined the contribution of metal nanoparticles to the onset of metal allergy by using Ag nanoparticles or nickel (Ni) nanoparticles with several kinds of diameters (63) (Figure 2). We showed that mice sensitized with Ag nanoparticles or nickel nanoparticles plus LPS exposure, but not with metal ions, experienced allergic inflammation in response to both metal ions and metal nanoparticles in the elicitation phase. We also showed that LPS was necessary for sensitization to metal nanoparticles. However, gold and SiO2 nanoparticles, which are minimally ionizable, did not induce allergic inflammation, even when co-administered with LPS. In addition, smaller metal nanoparticles had stronger sensitization potential than larger ones. We observed that CD4+ T cells were required for immune responses induced by metal nanoparticles and IL-17A-mediated inflammation was responsible for the allergic responses. On the basis of this study, we suggested that metal nanoparticles might play a role as a carrier, conveying metal ions to the lymph nodes for metal sensitization, because we found that smaller metal nanoparticles were transferred to the draining lymph nodes more readily than larger metal nanoparticles and metal ions. This study identifies metal nanoparticles as a new potential trigger of metal allergy and highlights the need to pay close attention to the indirect sensitization potential of metal nanoparticles when evaluating their safety.
Figure 2. Metal nanoparticles as a potential trigger of metal allergy. Metal-based fashion accessories may expose the wearer to metal ions that generate metal nanoparticles. These metal nanoparticles are then translocated to the lymph nodes where they release metal ions that induce metal ion-specific CD4+ T cells and IL-17-mediated immune responses.
Combined Exposure to Nanomaterials and Other Substances
Our skin is often exposed to nanomaterials simultaneously with other chemical compounds and allergens, such as foods and pollen. Therefore, it is important to examine the possibility that skin exposure to nanomaterials contributes to allergen-induced onset of allergy.
Allergic contact dermatitis is generally induced by a chemical sensitizer. Hussain et al. showed the effect of TiO2 nanoparticles with a diameter of 22 nm on the sensitization potential of dinitrochlorobenzene (DNCB), a well-known skin sensitizer (64). They showed that subcutaneous injection of TiO2 nanoparticles before DNCB treatment increased DNCB-mediated lymph node proliferation in an LLNA and enhanced Th2-type cytokine production, whereas TiO2 nanoparticles alone showed no dermal sensitization. This study suggests that some nanomaterials can enhance the sensitization potential of chemical sensitizers when they penetrate the skin. Moreover, several reports have shown that topical application of nanomaterials also has an effect on skin sensitization caused by chemicals. Lee et al. showed that 3 days of consecutive skin painting with mesoporous SiO2 nanoparticles with a diameter of about 100 nm and 2,4-dinitroflourobenzene (DNFB) exacerbated DNFB-induced ear skin thickness and lymphocyte proliferation (49). Smulders et al. compared the effect of different topically applied nanoparticles (TiO2, Ag, and SiO2 nanoparticles) on DNCB-induced dermal sensitization by an LLNA (65). They showed that only TiO2 nanoparticles enhanced sensitization to DNCB by augmenting a Th2 response. Together, these reports demonstrate that some nanomaterials can enhance the potential of chemical sensitizers after either topical application or intradermal/subcutaneous injection, although the physiochemical properties of the nanomaterials (e.g., size, shape, composition, charge, and surface energy) might influence the effects. Further studies are needed to reveal the mechanisms behind these nanomaterial effects and to identify the threshold amounts that are hazardous.
It is estimated that 15–30% of children and 2–10% of adults suffer from atopic dermatitis (66). Atopic dermatitis is believed to progress to allergic rhinitis and asthma over time, which is referred to as the atopic march. Of note, the incidence of atopic dermatitis has increased gradually in industrialized countries (67, 68). Some reports have shown that co-exposure to nanomaterials and protein allergens affect atopic allergy. Yanagisawa et al. showed that intradermal injection of TiO2 nanoparticles of different sizes (15, 50, or 100 nm) together with mite allergen, which is a major cause of atopic dermatitis, enhanced atopic dermatitis-like skin lesions and Th2-type cytokine production, as well as total IgE and histamine levels in serum (69). They observed that the size of the TiO2 nanoparticles did not influence these effects. They also observed similar effects in NC/Nga mice treated with polystyrene nanoparticles (70). In this case, enhancement of allergic responses was totally depended on the size of particle, that is, the smaller polystyrene nanoparticles induced greater symptoms. We also investigated the co-exposure effects of SiO2 particles of different sizes (30, 70, 100, 300, or 1000 nm) and mite antigen on atopic dermatitis in NC/Nga mice (71), and found that intradermal exposure of SiO2 particles and mite antigen aggravated atopic dermatitis. This effect was correlated with excessive induction of total IgE and stronger systemic Th2 responses. Of note, the aggravating effects were more pronounced in the smaller SiO2 nanoparticle-injected mice than in the mice exposed to the larger particles.
Other reports have shown the effects of nanomaterials on atopic dermatitis after topical skin painting. Ilves et al. used a mouse model of atopic dermatitis and showed that ZnO nanoparticles with a diameter of 20 nm cause an increase in IgE production after repeated topical application. However, these nanoparticles decreased local skin inflammatory responses, such as cytokine induction, in this mouse model (38). Our group showed that topical skin painting with a mixture of SiO2 nanoparticles and mite allergen suppressed allergen-specific IgG production without any changes in the IgE and Th1/Th2 immune responses (72). In addition, the suppression of IgG caused severe IgE-mediated hypersensitivity in an anaphylaxis model. Interestingly, low-level IgG production was induced when the mice were exposed to allergen-SiO2 nanoparticle agglomerates, but not when the mice were exposed to nanoparticles applied separately from the allergen, to well-dispersed nanoparticles, or to nanoparticle agglomerates via routes other than the skin. Thus, agglomeration of the allergen and SiO2 nanoparticles may have created a “depot” effect that could control the concentration of the exposed allergen and prolong allergen exposure. Thereby, we suggest that allergen-SiO2 nanoparticle agglomerates facilitated IgE-biased allergic sensitization.
These reports suggest that any nanomaterials could control the immune responses induced by a chemical sensitizer or allergen on the skin of humans. However, the mechanism responsible for these effects remains unclear. In the study described above, Smulders et al. observed that titanium levels were increased in lymph node cells after topical application of TiO2 nanoparticles, indicating that TiO2 nanoparticles penetrated the skin and translocated to the lymph nodes (65). We know that nanomaterials (<100 nm) can move to the draining lymph nodes via lymphatic vessels, but larger particles become trapped in the tissue and tend to depot near the site of injection (73). Winter et al. showed that TiO2 and SiO2 nanoparticles induce the activation of murine dendritic cells in vitro by upregulating co-stimulatory molecules (74). Therefore, one of the immunomodulating mechanisms of nanomaterials might be that they move to the draining lymph nodes after topical application and activate dendritic cells in the lymph nodes. However, little is understood about how nanomaterials affect the function of immune cells such as LCs and γδ T cells in the skin. In addition, as mentioned earlier, hair follicles have recently been revealed to have important functions in regulating the trafficking of LCs and skin-resident memory T cells (29, 75), and nanomaterials are prone to accumulate in hair follicles. Future studies should include detailed investigations into the relationship between the qualitative and quantitative distribution of nanomaterials in the skin and the effects of nanomaterials on skin immune cells, keratinocytes, and hair follicles.
We also must pay attention to the interaction of nanomaterials with antigens. Nanomaterials can bind more antigen per mass unit than larger particles, because nanomaterials have a larger per unit surface area per mass than larger particles. This leads to an enhancement of antigen persistence and prolonged release, an effect referred to as the “depot effect.” It has been suggested that smaller TiO2 nanoparticles bind more protein antigen per mass unit than larger ones and that the depot effect on the antigen due to this binding may lead to increased antigenicity (76). Furthermore, as described below, one of the immune-activating mechanisms of aluminum salts, which are a well-known vaccine adjuvant, is believed to involve the depot effect. Therefore, the depot effect might also be one of the immune-enhancing mechanisms of nanomaterials, particularly when co-exposed with antigens.
As noted earlier, our study showed that the depot effect by allergen–SiO2 nanoparticle agglomerates might modulate the exposure level of allergens on the skin and could change the immune responses, even though these allergen–SiO2 nanoparticle agglomerates could not penetrate the skin (72). In fact, our group found that differences in the cutaneous exposure level of allergens modulates the level of allergen-specific IgG and affects susceptibility to the IgE-mediated allergic response observed in other report (77). Therefore, allergen–nanomaterial aggregates and agglomerates might modulate immune responses via persistent release of allergen, even though the complexes are not able to penetrate the stratum corneum or tight junctions of the epidermis. These results suggest that we must examine several types of depot effects of complexes between nanomaterials and allergens.
The Protein Corona, Nanomaterials, and Complement
As described above, it is important to pay attention to the binding of compounds with nanomaterials. It is generally understood that nanomaterials could interact with proteins and other biomolecules contained in a biological fluid, when nanomaterials enter a biological fluid such as blood. For example, proteins bind to nanomaterials to form a coating around the surface known as the protein corona; when nanomaterials are mixed with plasma, the protein corona forms rapidly (within 30 seconds) (78). The protein composition of the corona does not seem to change markedly over time, although the concentration of a specific protein in the corona may change (78). Therefore, we must consider the possibility that the protein corona is involved in one or more of the mechanisms underlying the immunomodulating effects of nanomaterials.
The formation of the protein corona is an important factor that determines the interactions of nanomaterials with cells. Lesniak et al. reported that the protein corona surrounding nanomaterials inhibits the adhesion of nanomaterials to the cell membrane, resulting in a low internalization efficiency (79). In addition, they showed that the protein corona modulates not only the amount of nanomaterial taken up into cells but also the intracellular localization of nanomaterials within cells. Furthermore, detailed examination of the proteins within the corona has suggested that not all proteins in the protein corona modulate the cellular uptake of nanomaterials. For example, Deng et al. showed in in vitro studies that negatively charged gold nanoparticles bind to fibrinogen (80), and that the interaction of gold nanoparticles with fibrinogen induces fibrinogen unfolding, which promotes an interaction with the integrin receptor, Mac-1, which is expressed on macrophages. The binding and activation of Mac-1 induces inflammatory responses in macrophages. Therefore, the protein corona might contribute to the immunomodulatory effects of some nanomaterials. Indeed, if the protein corona of nanoparticles contains complement and coagulation factors, it can induce complement activation and blood clotting followed by unwanted inflammatory responses (81–84). The complement system not only works as an innate immune sensor but also plays an essential role as a trigger for inducing adaptive immunity. Although few studies have examined whether the protein corona containing complement proteins could contribute to the immunomodulatory effects of nanomaterials, some studies have suggested strategies involving the use of complement activation by nanomaterials as an adjuvant for vaccines (85, 86). Reddy et al. designed pluronic-stabilized polypropylene sulfide nanoparticles with a diameter of 25 nm that could strongly activate complement (85). They showed that the nanoparticle-conjugated antigen could induce antigen-specific immune responses. In the future, the effects of complement activation by nanomaterials on the onset of allergic responses should be investigated. In addition, few studies have systemically examined the relationship between the activation of complement and the surface properties of particles, because protein binding, including complement binding to nanomaterials, is known to depend on the physicality of nanomaterials, such as their size and surface properties (87). Elucidation of the fundamental rules that govern complement recognition of nanomaterials could help us to better predict the immunomodulatory effects of nanomaterials in the future.
Immunomodulating Mechanisms of the Adjuvant Effects of Particles
As described above, many nanomaterials have been reported to have the potential to enhance adaptive immunity, that is, they have adjuvant effects. However, the molecular mechanisms of the adjuvanticity of nanomaterials remain largely unknown. Many particles besides nanomaterials have been reported to have adjuvant effects, such as hemozoin, which is a heme metabolite during malaria infection, chitin particles from fungal cell walls, and monosodium urate crystals released from damaged cells (88–90). Aluminum salt is a well-known particle adjuvant that is widely used throughout the world as an adjuvant for human vaccines (91). Since aluminum salts are the most studied particle with adjuvant effects, we will introduce aluminum salts as a typical example to summarize the mechanism of adjuvant effects in the context of the immunomodulatory effects of nanomaterials.
About one century ago, the usefulness of aluminum, in its potassium salt form, as a vaccine adjuvant was described for the first time (92). Since this report, several reports have shown the adjuvant effects of aluminum salts, especially aluminum oxyhydroxide, because aluminum salts induce strong antigen-specific Th2 immune responses such as the production of IL-4 and IL-5 and the induction of IgE and IgG1. Nowadays, many vaccines formulated with aluminum salts, such as the diphtheria-tetanus-pertussis vaccine, the pneumococcal conjugate vaccine, and hepatitis B vaccine, are approved by the US Food and Drug Administration (93). Recently, progress was made in revealing the mode of action of aluminum salts, although a large part of the adjuvant mechanism remains unclear.
The surface charge of aluminum salts is positive at physiological pH and aluminum salts can bind to negatively charged compounds, including protein antigens (94, 95). Therefore, the depot effect is thought to play a part in the adjuvanticity of aluminum salts. However, some studies have questioned the importance of depot effects in the adjuvanticity of aluminum salts (96–98). For example, Hutchison et al. showed that surgical removal of the injection site 2 hours after co-administration of antigen and aluminum salts had no effect on antigen-specific immune responses in mice (96). Thus, it may be that aluminum salts have additional effects that contribute to their adjuvanticity, with the depot effect being just one of the underlying mechanisms.
The NLRP3 inflammasome is gaining attention for its role in the initial stages of inflammation, such as the production of IL-1β and IL-18, which are generated in response to a number of diverse particles, including monosodium urate crystal, silica, asbestos, and aluminum salts (99–101). Some reports have shown that aluminum salts induce antigen-specific IgG1 responses that are dependent on the NLRP3 inflammasome (101, 102), although other reports suggest that the NLRP3 inflammasome is not required for the adjuvanticity of aluminum salts (103, 104). This discrepancy might stem from differences in the aluminum salts (Imject alum (101, 102) or aluminum hydroxide (103, 104)) or mice (C57BL/6 (101, 102, 104) or mixed C57BL/6–129 (103)) used in the studies, and the importance of the NLRP3 inflammasome for the adjuvanticity of aluminum salts remains controversial. Recently, it was revealed that several types of nanomaterials induce NLRP3 activation (105). For example, Simard et al. showed in vitro that Ag nanoparticles activate the NLRP3 inflammasome by inducing the degradation of the ER stress sensor ATF-6 (106). In addition, Sun et al. showed that NADPH oxidase-dependent NLRP3 inflammasome activation is crucial for the lung fibrosis induced by multiwalled carbon nanotubes (107). However, few studies have investigated the link between the activation of the NLRP3 inflammasome by nanomaterials and the induction of adaptive immunity. Detailed studies to test this hypothesis are expected.
Recently, Kuroda et al. explained the role of prostaglandin E2 (PGE2), a well-characterized proinflammatory lipid mediator, in the adjuvanticity of aluminum salts (108). Specifically, they clarified the importance of aluminum salt-induced PGE2 for antigen-specific IgE production, rather than IgG1 production. This information will be useful to elucidate the mechanistic basis of the aggravation effects of nanomaterials on IgE-related allergies upon co-exposure with allergens.
Recently, aluminum salt-induced cell death was reported to be an important function of adjuvanticity. Marichal et al. showed that DNA molecules released from dying host cells as a function of aluminum salt-induced innate immune responses act as damage-associated molecular patterns (DAMPs) to effectively induce adaptive immunity (109). In addition, Miki et al. showed that the interaction of apoptotic host cells, induced by aluminum salts, with CD300a, an immunoreceptor for phosphatidylserine, was important for the adjuvant effects of aluminum salts (110). Although many reports have examined the cytotoxicity of nanomaterials, few have shown the effects on the immune system of DAMPs and dead cells induced by nanomaterials. In this regard, Rabollil et al. showed that IL-1α from necrotic alveolar macrophages was important for SiO2 nanoparticle-induced lung inflammation (111), although the importance of this IL-1α production for the induction of adaptive immunity was not clear. Recently, Kuroda et al. also indicated that IL-1α release from alveolar macrophage death induced by aluminum salts contribute to adjuvant activity in the lungs (112). Since LPS stimulation induce alveolar macrophage death and IL-1α release (113), IL-1α release in the lungs seems an important event for immune responses in the lung. In addition, Natsuaki et al. showed that IL-1α-induced leukocyte clusters is important for efficient activation of T cells in skin (114), suggesting the essential immunological role of IL-1α in skin. Cell death might be required for allergic responses in the skin, the precise mechanisms involved in cell death in skin after exposure to nanomaterials should be investigated.
Many reports have shown the seemingly linear relationship between the biological effects of nanomaterials and their size. However, several in vitro studies have shown that nanomaterials with a diameter of 50 nm induce more cellular uptake or cytotoxicity compared with their larger and smaller counterparts (115, 116), suggesting the existence of size-specific nanotoxicity. Yet, few reports have shown such size-specific effects of nanomaterials in vivo. Therefore, further studies are needed to elucidate the size-specific immunomodulating mechanisms of nanomaterials, which might be different from those of aluminum salts.
Future Prospects and Conclusion
It is difficult to judge whether topical application of nanomaterials to healthy skin poses a risk for disruption of immune homeostasis, because most nanomaterials cannot penetrate healthy skin. On the other hand, there is an urgent need to identify the potential of nanomaterials to cause sensitization either directly or via co-exposure with substances in people with allergic diseases and damaged skin. In this regard, there are many unresolved problems.
Recently, new information surfaced regarding the relationship between commensal bacteria and the host’s immune system: the commensal bacteria on the skin may in fact influence the host’s immune system (117, 118). For example, microbial diversity on skin is known to be markedly reduced in patients with atopic dermatitis, and treatment could restore this diversity (119). Therefore, we may need to consider both the direct effects of nanomaterials on the microbiota on skin and the indirect effects of nanomaterials on host immune systems via changes in the diversity and composition of the microbiota on skin. In addition, most bacteria have pathogen-associated molecular patterns (PAMPs), which are ligands of pattern recognition receptors, such as Toll-like receptors, Nod-like receptors, RIG-I-like receptors, and C-type lectin receptors (120). PAMPs could induce innate immunity, mediated by macrophages and dendritic cells, and activate innate immunity, such as the production of cytokines and chemokines, to induce effective adaptive immunity. Therefore, we need in-depth studies of the co-exposure effects of PAMPs and nanomaterials, in addition to the effects of DAMPs.
A range of toxicological studies have been conducted assessing various physicochemical characteristics of nanomaterials, such as particle size, surface charge, surface hydrophobicity, particle shape, and states of agglomeration and aggregation. However, the results have been inconsistent to date and definitive rules cannot yet be established. Systematic information about the relationships among the physicochemical properties and biological effects of nanomaterials is still lacking.
Recent studies have revealed that particle-induced immune responses are involved in pathological processes of chronic inflammation such as allergy. It is not too much to say that the skin is the immune sentinel of our tissues. However, the underlying mechanisms of the effects of nanomaterials are not fully understood. To establish rules governing the contributions of nanomaterials to allergic responses, we need more information, including an understanding of the molecular mechanisms of action of nanomaterials. These future studies could promote ways for us to live in harmony with nanomaterials. Furthermore, such studies would provide useful information to improve the safety and efficacy of nanomaterials used in skincare.
Author Contributions
YY, EK, TH, YT, and KI wrote the article and prepared the figures.
Conflict of Interest Statement
YY is employed by The Research Foundation for Microbial Diseases of Osaka University. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Auffan M, Rose J, Bottero JY, Lowry GV, Jolivet JP, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol (2009) 4(10):634–41. doi: 10.1038/nnano.2009.242
2. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science (2012) 338(6109):903–10. doi:10.1126/science.1226338
3. Bowman DM, van Calster G, Friedrichs S. Nanomaterials and regulation of cosmetics. Nat Nanotechnol (2010) 5(2):92. doi:10.1038/nnano.2010.12
4. Fruijtier-Polloth C. The safety of nanostructured synthetic amorphous silica (SAS) as a food additive (E 551). Arch Toxicol (2016) 90(12):2885–916. doi:10.1007/s00204-016-1850-4
5. Xia T, Li N, Nel AE. Potential health impact of nanoparticles. Annu Rev Public Health (2009) 30:137–50. doi:10.1146/annurev.publhealth.031308.100155
6. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta (2011) 1810(3):361–73. doi:10.1016/j.bbagen.2010.04.007
7. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol (2011) 6(5):321–8. doi:10.1038/nnano.2011.41
8. Song Y, Li X, Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J (2009) 34(3):559–67. doi:10.1183/09031936.00178308
9. Liao HY, Chung YT, Lai CH, Lin MH, Liou SH. Sneezing and allergic dermatitis were increased in engineered nanomaterial handling workers. Ind Health (2014) 52(3):199–215. doi:10.2486/indhealth.2013-0100
10. Wu WT, Liao HY, Chung YT, Li WF, Tsou TC, Li LA, et al. Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials. Int J Mol Sci (2014) 15(1):878–94. doi:10.3390/ijms15010878
11. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol (2007) 2(8):469–78. doi:10.1038/nnano.2007.223
12. Shannahan JH, Brown JM. Engineered nanomaterial exposure and the risk of allergic disease. Curr Opin Allergy Clin Immunol (2014) 14(2):95–9. doi:10.1097/ACI.0000000000000031
13. Farrera C, Fadeel B. It takes two to tango: understanding the interactions between engineered nanomaterials and the immune system. Eur J Pharm Biopharm (2015) 95(Pt A):3–12. doi:10.1016/j.ejpb.2015.03.007
14. Wang SQ, Tooley IR. Photoprotection in the era of nanotechnology. Semin Cutan Med Surg (2011) 30(4):210–3. doi:10.1016/j.sder.2011.07.006
15. Nafisi S, Schafer-Korting M, Maibach HI. Perspectives on percutaneous penetration: silica nanoparticles. Nanotoxicology (2015) 9(5):643–57. doi:10.3109/17435390.2014.958115
16. Schluesener JK, Schluesener HJ. Nanosilver: application and novel aspects of toxicology. Arch Toxicol (2013) 87(4):569–76. doi:10.1007/s00204-012-1007-z
17. Krpetic Z, Anguissola S, Garry D, Kelly PM, Dawson KA. Nanomaterials: impact on cells and cell organelles. Adv Exp Med Biol (2014) 811:135–56. doi:10.1007/978-94-017-8739-0_8
18. Valenta R, Hochwallner H, Linhart B, Pahr S. Food allergies: the basics. Gastroenterology (2015) 148(6):1120e–31e. doi:10.1053/j.gastro.2015.02.006
19. Yu W, Freeland DM, Nadeau KC. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol (2016) 16(12):751–65. doi:10.1038/nri.2016.111
20. Tordesillas L, Goswami R, Benede S, Grishina G, Dunkin D, Jarvinen KM, et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest (2014) 124(11):4965–75. doi:10.1172/JCI75660
21. Noti M, Kim BS, Siracusa MC, Rak GD, Kubo M, Moghaddam AE, et al. Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. J Allergy Clin Immunol (2014) 133(5):e1–6. doi:10.1016/j.jaci.2014.01.021
22. Oyoshi MK, Oettgen HC, Chatila TA, Geha RS, Bryce PJ. Food allergy: insights into etiology, prevention, and treatment provided by murine models. J Allergy Clin Immunol (2014) 133(2):309–17. doi:10.1016/j.jaci.2013.12.1045
23. Lauriere M, Pecquet C, Bouchez-Mahiout I, Snegaroff J, Bayrou O, Raison-Peyron N, et al. Hydrolysed wheat proteins present in cosmetics can induce immediate hypersensitivities. Contact Dermatitis (2006) 54(5):283–9. doi:10.1111/j.0105-1873.2006.00830.x
24. Nakamura M, Yagami A, Hara K, Sano-Nagai A, Kobayashi T, Matsunaga K. Evaluation of the cross-reactivity of antigens in Glupearl 19S and other hydrolysed wheat proteins in cosmetics. Contact Dermatitis (2016) 74(6):346–52. doi:10.1111/cod.12551
25. Jatana S, DeLouise LA. Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposure. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 6(1):61–79. doi:10.1002/wnan.1244
26. Brandner JM, Zorn-Kruppa M, Yoshida T, Moll I, Beck LA, De Benedetto A. Epidermal tight junctions in health and disease. Tissue Barriers (2015) 3(1–2):e974451. doi:10.4161/21688370.2014.974451
27. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol (2000) 9(3):165–9. doi:10.1034/j.1600-0625.2000.009003165.x
28. Chourasia R, Jain SK. Drug targeting through pilosebaceous route. Curr Drug Targets (2009) 10(10):950–67. doi:10.2174/138945009789577918
29. Nagao K, Kobayashi T, Moro K, Ohyama M, Adachi T, Kitashima DY, et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol (2012) 13(8):744–52. doi:10.1038/ni.2353
30. Honda T, Egawa G, Grabbe S, Kabashima K. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol (2013) 133(2):303–15. doi:10.1038/jid.2012.284
31. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med (2009) 206(13):2937–46. doi:10.1084/jem.20091527
32. Yoshida K, Kubo A, Fujita H, Yokouchi M, Ishii K, Kawasaki H, et al. Distinct behavior of human langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol (2014) 134(4):856–64. doi:10.1016/j.jaci.2014.08.001
33. Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol (2007) 20(3):148–54. doi:10.1159/000098701
34. Larese FF, D’Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, et al. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology (2009) 255(1–2):33–7. doi:10.1016/j.tox.2008.09.025
35. Lin LL, Grice JE, Butler MK, Zvyagin AV, Becker W, Robertson TA, et al. Time-correlated single photon counting for simultaneous monitoring of zinc oxide nanoparticles and NAD(P)H in intact and barrier-disrupted volunteer skin. Pharm Res (2011) 28(11):2920–30. doi:10.1007/s11095-011-0515-5
36. Gulson B, McCall M, Korsch M, Gomez L, Casey P, Oytam Y, et al. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci (2010) 118(1):140–9. doi:10.1093/toxsci/kfq243
37. Gulson B, Wong H, Korsch M, Gomez L, Casey P, McCall M, et al. Comparison of dermal absorption of zinc from different sunscreen formulations and differing UV exposure based on stable isotope tracing. Sci Total Environ (2012) 420:313–8. doi:10.1016/j.scitotenv.2011.12.046
38. Ilves M, Palomaki J, Vippola M, Lehto M, Savolainen K, Savinko T, et al. Topically applied ZnO nanoparticles suppress allergen induced skin inflammation but induce vigorous IgE production in the atopic dermatitis mouse model. Part Fibre Toxicol (2014) 11:38. doi:10.1186/s12989-014-0038-4
39. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol (2006) 126(6):1316–22. doi:10.1038/sj.jid.5700226
40. Rancan F, Gao Q, Graf C, Troppens S, Hadam S, Hackbarth S, et al. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano (2012) 6(8):6829–42. doi:10.1021/nn301622h
41. Mortensen LJ, Oberdorster G, Pentland AP, Delouise LA. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett (2008) 8(9):2779–87. doi:10.1021/nl801323y
42. Patzelt A, Lademann J. Drug delivery to hair follicles. Expert Opin Drug Deliv (2013) 10(6):787–97. doi:10.1517/17425247.2013.776038
43. Papakostas D, Rancan F, Sterry W, Blume-Peytavi U, Vogt A. Nanoparticles in dermatology. Arch Dermatol Res (2011) 303(8):533–50. doi:10.1007/s00403-011-1163-7
44. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release (2004) 99(1):53–62. doi:10.1016/j.jconrel.2004.06.015
45. Patzelt A, Richter H, Knorr F, Schafer U, Lehr CM, Dahne L, et al. Selective follicular targeting by modification of the particle sizes. J Control Release (2011) 150(1):45–8. doi:10.1016/j.jconrel.2010.11.015
46. Lalko JF, Kimber I, Dearman RJ, Gerberick GF, Sarlo K, Api AM. Chemical reactivity measurements: potential for characterization of respiratory chemical allergens. Toxicol In Vitro (2011) 25(2):433–45. doi:10.1016/j.tiv.2010.11.007
47. van Loveren H, Cockshott A, Gebel T, Gundert-Remy U, de Jong WH, Matheson J, et al. Skin sensitization in chemical risk assessment: report of a WHO/IPCS international workshop focusing on dose-response assessment. Regul Toxicol Pharmacol (2008) 50(2):155–99. doi:10.1016/j.yrtph.2007.11.008
48. Park YH, Jeong SH, Yi SM, Choi BH, Kim YR, Kim IK, et al. Analysis for the potential of polystyrene and TiO2 nanoparticles to induce skin irritation, phototoxicity, and sensitization. Toxicol In Vitro (2011) 25(8):1863–9. doi:10.1016/j.tiv.2011.05.022
49. Lee S, Yun HS, Kim SH. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials (2011) 32(35):9434–43. doi:10.1016/j.biomaterials.2011.08.042
50. Mann E, Ranft U, Eberwein G, Gladtke D, Sugiri D, Behrendt H, et al. Does airborne nickel exposure induce nickel sensitization? Contact Dermatitis (2010) 62(6):355–62. doi:10.1111/j.1600-0536.2010.01725.x
51. Otani S, Onishi K, Mu H, Yokoyama Y, Hosoda T, Okamoto M, et al. The relationship between skin symptoms and allergic reactions to Asian dust. Int J Environ Res Public Health (2012) 9(12):4606–14. doi:10.3390/ijerph9124606
52. Swinnen I, Goossens A. An update on airborne contact dermatitis: 2007-2011. Contact Dermatitis (2013) 68(4):232–8. doi:10.1111/cod.12022
53. Thyssen JP, Linneberg A, Menne T, Johansen JD. The epidemiology of contact allergy in the general population – prevalence and main findings. Contact Dermatitis (2007) 57(5):287–99. doi:10.1111/j.1600-0536.2007.01220.x
54. Thyssen JP, Menne T. Metal allergy – a review on exposures, penetration, genetics, prevalence, and clinical implications. Chem Res Toxicol (2010) 23(2):309–18. doi:10.1021/tx9002726
55. Kimber I, Bentley AN, Hilton J. Contact sensitization of mice to nickel sulphate and potassium dichromate. Contact Dermatitis (1990) 23(5):325–30.
56. Vreeburg KJ, de Groot K, van Hoogstraten IM, von Blomberg BM, Scheper RJ. Successful induction of allergic contact dermatitis to mercury and chromium in mice. Int Arch Allergy Appl Immunol (1991) 96(2):179–83.
57. Artik S, von Vultee C, Gleichmann E, Schwarz T, Griem P. Nickel allergy in mice: enhanced sensitization capacity of nickel at higher oxidation states. J Immunol (1999) 163(3):1143–52.
58. Sato N, Kinbara M, Kuroishi T, Kimura K, Iwakura Y, Ohtsu H, et al. Lipopolysaccharide promotes and augments metal allergies in mice, dependent on innate immunity and histidine decarboxylase. Clin Exp Allergy (2007) 37(5):743–51. doi:10.1111/j.1365-2222.2007.02705.x
59. Johansen P, Wackerle-Men Y, Senti G, Kundig TM. Nickel sensitisation in mice: a critical appraisal. J Dermatol Sci (2010) 58(3):186–92. doi:10.1016/j.jdermsci.2010.03.011
60. Wiesner MR, Lowry GV, Casman E, Bertsch PM, Matson CW, Di Giulio RT, et al. Meditations on the ubiquity and mutability of nano-sized materials in the environment. ACS Nano (2011) 5(11):8466–70. doi:10.1021/nn204118p
61. Glover RD, Miller JM, Hutchison JE. Generation of metal nanoparticles from silver and copper objects: nanoparticle dynamics on surfaces and potential sources of nanoparticles in the environment. ACS Nano (2011) 5(11):8950–7. doi:10.1021/nn2031319
62. Yin Y, Liu J, Jiang G. Sunlight-induced reduction of ionic Ag and Au to metallic nanoparticles by dissolved organic matter. ACS Nano (2012) 6(9):7910–9. doi:10.1021/nn302293r
63. Hirai T, Yoshioka Y, Izumi N, Ichihashi K, Handa T, Nishijima N, et al. Metal nanoparticles in the presence of lipopolysaccharides trigger the onset of metal allergy in mice. Nat Nanotechnol (2016) 11(9):808–16. doi:10.1038/nnano.2016.88
64. Hussain S, Smulders S, De Vooght V, Ectors B, Boland S, Marano F, et al. Nano-titanium dioxide modulates the dermal sensitization potency of DNCB. Part Fibre Toxicol (2012) 9:15. doi:10.1186/1743-8977-9-15
65. Smulders S, Golanski L, Smolders E, Vanoirbeek J, Hoet PH. Nano-TiO2 modulates the dermal sensitization potency of dinitrochlorobenzene after topical exposure. Br J Dermatol (2015) 172(2):392–9. doi:10.1111/bjd.13295
66. Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol (2006) 118(1):209–13. doi:10.1016/j.jaci.2006.04.043
68. Plotz SG, Ring J. What’s new in atopic eczema? Expert Opin Emerg Drugs (2010) 15(2):249–67. doi:10.1517/14728211003792518
69. Yanagisawa R, Takano H, Inoue K, Koike E, Kamachi T, Sadakane K, et al. Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice. Exp Biol Med (Maywood) (2009) 234(3):314–22. doi:10.3181/0810-RM-304
70. Yanagisawa R, Takano H, Inoue KI, Koike E, Sadakane K, Ichinose T. Size effects of polystyrene nanoparticles on atopic dermatitis like skin lesions in NC/NGA mice. Int J Immunopathol Pharmacol (2010) 23(1):131–41. doi:10.1177/039463201002300112
71. Hirai T, Yoshikawa T, Nabeshi H, Yoshida T, Tochigi S, Ichihashi K, et al. Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection. Part Fibre Toxicol (2012) 9:3. doi:10.1186/1743-8977-9-3
72. Hirai T, Yoshioka Y, Takahashi H, Ichihashi K, Udaka A, Mori T, et al. Cutaneous exposure to agglomerates of silica nanoparticles and allergen results in IgE-biased immune response and increased sensitivity to anaphylaxis in mice. Part Fibre Toxicol (2015) 12:16. doi:10.1186/s12989-015-0095-3
73. Moyer TJ, Zmolek AC, Irvine DJ. Beyond antigens and adjuvants: formulating future vaccines. J Clin Invest (2016) 126(3):799–808. doi:10.1172/JCI81083
74. Winter M, Beer HD, Hornung V, Kramer U, Schins RP, Forster I. Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology (2011) 5(3):326–40. doi:10.3109/17435390.2010.506957
75. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med (2015) 21(11):1272–9. doi:10.1038/nm.3962
76. Larsen ST, Roursgaard M, Jensen KA, Nielsen GD. Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin Pharmacol Toxicol (2010) 106(2):114–7. doi:10.1111/j.1742-7843.2009.00473.x
77. Hirai T, Yoshioka Y, Takahashi H, Handa T, Izumi N, Mori T, et al. High-dose cutaneous exposure to mite allergen induces IgG-mediated protection against anaphylaxis. Clin Exp Allergy (2016) 46(7):992–1003. doi:10.1111/cea.12722
78. Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 8(10):772–81. doi:10.1038/nnano.2013.181
79. Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 6(7):5845–57. doi:10.1021/nn300223w
80. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2011) 6(1):39–44. doi:10.1038/nnano.2010.250
81. Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux JC, Benoit JP. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A (2006) 78(3):620–8. doi:10.1002/jbm.a.30711
82. Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials (2006) 27(24):4356–73. doi:10.1016/j.biomaterials.2006.03.039
83. Yoshida T, Yoshioka Y, Tochigi S, Hirai T, Uji M, Ichihashi K, et al. Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice. Part Fibre Toxicol (2013) 10:41. doi:10.1186/1743-8977-10-41
84. Yoshida T, Yoshioka Y, Morishita Y, Aoyama M, Tochigi S, Hirai T, et al. Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice. Nanotechnology (2015) 26(24):245101. doi:10.1088/0957-4484/26/24/245101
85. Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O’Neil CP, et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol (2007) 25(10):1159–64. doi:10.1038/nbt1332
86. Thomas SN, van der Vlies AJ, O’Neil CP, Reddy ST, Yu SS, Giorgio TD, et al. Engineering complement activation on polypropylene sulfide vaccine nanoparticles. Biomaterials (2011) 32(8):2194–203. doi:10.1016/j.biomaterials.2010.11.037
87. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano (2011) 5(9):7155–67. doi:10.1021/nn201950e
88. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int (1991) 40(4):632–42.
89. Coban C, Igari Y, Yagi M, Reimer T, Koyama S, Aoshi T, et al. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe (2010) 7(1):50–61. doi:10.1016/j.chom.2009.12.003
90. Kool M, Willart MA, van Nimwegen M, Bergen I, Pouliot P, Virchow JC, et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity (2011) 34(4):527–40. doi:10.1016/j.immuni.2011.03.015
91. Kuroda E, Coban C, Ishii KJ. Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects. Int Rev Immunol (2013) 32(2):209–20. doi:10.3109/08830185.2013.773326
92. Glenny AT, Pope CG, Waddington H, Wallace U. Immunological notes XVLL.-XXIV. J Pathol Bacteriol (1926) 29:31–40.
93. Baylor NW, Egan W, Richman P. Aluminum salts in vaccines – US perspective. Vaccine (2002) 20(Suppl 3):S18–23. doi:10.1016/S0264-410X(02)00166-4
94. al-Shakhshir R, Regnier F, White JL, Hem SL. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants. Vaccine (1994) 12(5):472–4.
95. Matheis W, Zott A, Schwanig M. The role of the adsorption process for production and control combined adsorbed vaccines. Vaccine (2001) 20(1–2):67–73. doi:10.1016/S0264-410X(01)00317-6
96. Hutchison S, Benson RA, Gibson VB, Pollock AH, Garside P, Brewer JM. Antigen depot is not required for alum adjuvanticity. FASEB J (2012) 26(3):1272–9. doi:10.1096/fj.11-184556
97. Shi Y, HogenEsch H, Hem SL. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines. Vaccine (2001) 20(1–2):80–5. doi:10.1016/S0264-410X(01)00313-9
98. Weissburg RP, Berman PW, Cleland JL, Eastman D, Farina F, Frie S, et al. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharm Res (1995) 12(10):1439–46.
99. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 440(7081):237–41. doi:10.1038/nature04516
100. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 9(8):847–56. doi:10.1038/ni.1631
101. Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 453(7198):1122–6. doi:10.1038/nature06939
102. Li H, Willingham SB, Ting JP, Re F. Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol (2008) 181(1):17–21. doi:10.4049/jimmunol.181.1.17
103. Franchi L, Nunez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol (2008) 38(8):2085–9. doi:10.1002/eji.200838549
104. McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol (2009) 183(7):4403–14. doi:10.4049/jimmunol.0900164
105. Rabolli V, Lison D, Huaux F. The complex cascade of cellular events governing inflammasome activation and IL-1beta processing in response to inhaled particles. Part Fibre Toxicol (2016) 13(1):40. doi:10.1186/s12989-016-0150-8
106. Simard JC, Vallieres F, de Liz R, Lavastre V, Girard D. Silver nanoparticles induce degradation of the endoplasmic reticulum stress sensor activating transcription factor-6 leading to activation of the NLRP-3 inflammasome. J Biol Chem (2015) 290(9):5926–39. doi:10.1074/jbc.M114.610899
107. Sun B, Wang X, Ji Z, Wang M, Liao YP, Chang CH, et al. NADPH oxidase-dependent NLRP3 inflammasome activation and its important role in lung fibrosis by multiwalled carbon nanotubes. Small (2015) 11(17):2087–97. doi:10.1002/smll.201402859
108. Kuroda E, Ishii KJ, Uematsu S, Ohata K, Coban C, Akira S, et al. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity (2011) 34(4):514–26. doi:10.1016/j.immuni.2011.03.019
109. Marichal T, Ohata K, Bedoret D, Mesnil C, Sabatel C, Kobiyama K, et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med (2011) 17(8):996–1002. doi:10.1038/nm.2403
110. Miki H, Nakahashi-Oda C, Sumida T, Shibuya A. Involvement of CD300a phosphatidylserine immunoreceptor in aluminum salt adjuvant-induced Th2 responses. J Immunol (2015) 194(11):5069–76. doi:10.4049/jimmunol.1402915
111. Rabolli V, Badissi AA, Devosse R, Uwambayinema F, Yakoub Y, Palmai-Pallag M, et al. The alarmin IL-1alpha is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles. Part Fibre Toxicol (2014) 11:69. doi:10.1186/s12989-014-0069-x
112. Kuroda E, Ozasa K, Temizoz B, Ohata K, Koo CX, Kanuma T, et al. Inhaled fine particles induce alveolar macrophage death and interleukin-1alpha release to promote inducible bronchus-associated lymphoid tissue formation. Immunity (2016) 45(6):1299–310. doi:10.1016/j.immuni.2016.11.010
113. Dagvadorj J, Shimada K, Chen S, Jones HD, Tumurkhuu G, Zhang W, et al. Lipopolysaccharide induces alveolar macrophage necrosis via CD14 and the P2X7 receptor leading to interleukin-1alpha release. Immunity (2015) 42(4):640–53. doi:10.1016/j.immuni.2015.03.007
114. Natsuaki Y, Egawa G, Nakamizo S, Ono S, Hanakawa S, Okada T, et al. Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin. Nat Immunol (2014) 15(11):1064–9. doi:10.1038/ni.2992
115. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol (2008) 3(3):145–50. doi:10.1038/nnano.2008.30
116. Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small (2009) 5(12):1408–13. doi:10.1002/smll.200900005
117. Wesemann DR, Nagler CR. The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease. Immunity (2016) 44(4):728–38. doi:10.1016/j.immuni.2016.02.002
118. Nakamizo S, Egawa G, Honda T, Nakajima S, Belkaid Y, Kabashima K. Commensal bacteria and cutaneous immunity. Semin Immunopathol (2015) 37(1):73–80. doi:10.1007/s00281-014-0452-6
119. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res (2012) 22(5):850–9. doi:10.1101/gr.131029.111
Keywords: adjuvant, allergy, aluminum salts, biodistribution, metal allergy, nanomaterial, sensitization, skin
Citation: Yoshioka Y, Kuroda E, Hirai T, Tsutsumi Y and Ishii KJ (2017) Allergic Responses Induced by the Immunomodulatory Effects of Nanomaterials upon Skin Exposure. Front. Immunol. 8:169. doi: 10.3389/fimmu.2017.00169
Received: 28 December 2016; Accepted: 02 February 2017;
Published: 16 February 2017
Edited by:
Diana Boraschi, National Research Council, ItalyReviewed by:
Albert Duschl, University of Salzburg, AustriaDetlef Neumann, Hannover Medical School, Germany
Copyright: © 2017 Yoshioka, Kuroda, Hirai, Tsutsumi and Ishii. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yasuo Yoshioka, y-yoshioka@biken.osaka-u.ac.jp